Who owns BOLT BIOTHERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Bolt Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Bolt Biotherapeutics stock

Who bought or sold BOLT BIOTHERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Sofinnova Ventures 138k $530k 0% Jun 2026
 View chart
Renaissance Technologies 99k $380k 28% Jun 2026
 View chart
Vivo Capital 72k $279k 0% Jun 2026
 View chart
Citadel Advisors 57k $219k 463% Jun 2026
 View chart
T3 Companies 38k $146k 0% Jun 2026
 View chart
Board of Trustees of The Leland Stanford Junior University 36k $139k 0% Jun 2026
 View chart
Pfizer 31k $134k 0% Jun 2026
 View chart
Lynx1 Capital Management 31k $119k 0% Jun 2026
 View chart
Nano Cap New Millennium Growth Fund 28k $106k 0% Jun 2026
 View chart
Geode Capital Management 19k $74k -34% Jun 2026
 View chart
Shay Capital 15k $59k 4% Jun 2026
 View chart
BlackRock 9.7k $37k 0% Jun 2026
 View chart
Vanguard Capital Management 7.1k $27k 0% Jun 2026
 View chart
Nan Fung Group Holdings 5.0k $19k -83% Jun 2026
 View chart
Morgan Stanley 3.2k $13k 2% Mar 2026
 View chart
Vanguard Fiduciary Trust 3.1k $12k 0% Jun 2026
 View chart
Goss Wealth Management 2.5k $9.7k 100% Jun 2026
 View chart
Tower Research Capital 1.7k $6.6k 56% Jun 2026
 View chart
Mercer Global Advisors 292.00 $1.1k 100% Jun 2026
 View chart
UBS Group 255.00 $1.0k -68% Jun 2026
 View chart
SBI Securities 130.00 $500.994000 1200% Jun 2026
 View chart
Jpmorgan Chase & Co 42.00 $165.001200 100% Jun 2026
 View chart
Barclays 6.00 $22.999800 0% Jun 2026
 View chart

Who sold out of Bolt Biotherapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Pivotal bioVenture Partners Investment Advisor Mar 2026 43k $172k
Susquehanna International Mar 2026 12k $47k
Vanguard Global Advisers Mar 2026 24.00 $97.000800